Final Class II Order, Special Controls For Hemoglobin A1c Tests Set
This article was originally published in The Gray Sheet
FDA spells out the special controls needed for class II specification of hemoglobin A1c test systems in a final order taking effect Sept. 24.
You may also be interested in...
Bausch & Lomb gets approval for first-of-a-kind intraocular lens. Roche HbA1c assay is first to be cleared to diagnose diabetes. More product launches and approvals from the past week.
Stephen Hahn’s low visibility period as the newly installed FDA commissioner comes to an abrupt end. Trump offers generous praise amid COVID-19 response – but how quickly might that change to blame?
The latest drug development news and highlights from the Pink Sheet US FDA Performance Tracker.